Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Microscopy Research and Technique|February 19, 2000
Progress in myoblast transplantation: a potential treatment of dystrophiesD Skuk, J P TremblayCell Transplantation|October 24, 1998
Complement deposition and cell death after myoblast transplantationD Skuk, J P TremblayJournal of Neuropathology and Experimental Neurology|April 1, 2000
Myoblast transplantation in whole muscle of nonhuman primatesD Skuk, M Goulet, B Roy, et al.Experimental Neurology|January 27, 1999
Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscleD Skuk, B Roy, M Goulet, et al.Cell Transplantation|March 1, 1997
Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantationB Guérette, I Asselin, D Skuk, et al.Biochemical and Biophysical Research Communications|June 24, 1998
Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigeneP A Moisset, D Skuk, I Asselin, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|July 23, 2003
Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation successE El Fahime, M Bouchentouf, B F Benabdallah, et al.Journal of Neuropathology and Experimental Neurology|September 28, 1999
Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophyD Skuk, D Furling, J P Bouchard, et al.Human Gene Therapy|July 13, 2000
Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblastsP A Moisset, L Bonham, D Skuk, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1997
Prevention by anti-LFA-1 of acute myoblast death following transplantationB Guérette, D Skuk, F Célestin, et al.Pageof 12